BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38405005)

  • 21. The association of health insurance and race with treatment and survival in patients with metastatic colorectal cancer.
    Mitsakos AT; Irish W; Parikh AA; Snyder RA
    PLoS One; 2022; 17(2):e0263818. PubMed ID: 35176030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
    Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
    Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial inequity and other social disparities in the diagnosis and management of bladder cancer.
    Hasan S; Lazarev S; Garg M; Mehta K; Press RH; Chhabra A; Choi JI; Simone CB; Gorovets D
    Cancer Med; 2023 Jan; 12(1):640-650. PubMed ID: 35674112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nationwide analysis of disparities in guideline-concordant care in American Indians and Alaska Natives with stage I non-small cell lung cancer.
    Schoephoerster J; Praska C; White M; Salami A; Marmor S; Andrade R; Bhargava A; Diaz-Gutierrez I; Hui J; Tuttle T; Owen M; Rao M
    J Thorac Dis; 2023 Nov; 15(11):5891-5900. PubMed ID: 38090326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are There Racial or Socioeconomic Disparities in Ambulatory Outcome or Survival After Oncologic Spine Surgery for Metastatic Cancer? Results From a Medically Underserved Center.
    De la Garza Ramos R; Javed K; Ryvlin J; Gelfand Y; Murthy S; Yassari R
    Clin Orthop Relat Res; 2023 Feb; 481(2):301-307. PubMed ID: 36198109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.
    Shah NN; Xi Y; Liu Y; Koff JL; Flowers CR; Behera M; Cohen JB
    Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e312-e320. PubMed ID: 31029647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer.
    Toubat O; Atay SM; Kim AW; Ding L; Farias AJ; Ebner PJ; McFadden PM; David EA
    Ann Thorac Surg; 2020 May; 109(5):1512-1520. PubMed ID: 31982443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
    Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
    Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparities in Systemic Treatment Use in Advanced-stage Non-Small Cell Lung Cancer by Source of Health Insurance.
    Maguire FB; Morris CR; Parikh-Patel A; Cress RD; Keegan THM; Li CS; Lin PS; Kizer KW
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1059-1066. PubMed ID: 30842132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial Disparity and Social Determinants in Receiving Timely Surgery Among Stage I-IIIA Non-small Cell Lung Cancer Patients in a U.S. Southern State.
    Neroda P; Hsieh MC; Wu XC; Cartmell KB; Mayo R; Wu J; Hicks C; Zhang L
    Front Public Health; 2021; 9():662876. PubMed ID: 34150706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-small cell lung cancer treatment receipt and survival among African-Americans and whites in a rural area.
    Hua X; Ward KC; Gillespie TW; Lipscomb J; Goodman M
    J Community Health; 2014 Aug; 39(4):696-705. PubMed ID: 24346819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urban/rural patterns in receipt of treatment for non-small cell lung cancer among black and white Medicare beneficiaries, 2000-2003.
    Steele CB; Pisu M; Richardson LC
    J Natl Med Assoc; 2011 Aug; 103(8):711-8. PubMed ID: 22046848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer.
    Williams CD; Salama JK; Moghanaki D; Karas TZ; Kelley MJ
    J Thorac Oncol; 2016 Oct; 11(10):1672-81. PubMed ID: 27296104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial Disparities in Overall Survival and Surgical Treatment for Early Stage Lung Cancer by Facility Type.
    Merritt RE; Abdel-Rasoul M; D'Souza DM; Kneuertz PJ
    Clin Lung Cancer; 2021 Sep; 22(5):e691-e698. PubMed ID: 33597104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States.
    Hao S; Snyder RA; Irish W; Parikh AA
    PLoS Med; 2021 Oct; 18(10):e1003842. PubMed ID: 34695123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
    Cassidy RJ; Zhang X; Switchenko JM; Patel PR; Shelton JW; Tian S; Nanda RH; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD; Gillespie TW; Curran WJ; Higgins KA
    Cancer; 2018 Feb; 124(4):775-784. PubMed ID: 29315497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of racial disparities and insurance status in patients with bone sarcomas in the USA : a population-based cohort study.
    Hu X; Fujiwara T; Houdek MT; Chen L; Huang W; Sun Z; Sun Y; Yan W
    Bone Joint Res; 2022 May; 11(5):278-291. PubMed ID: 35549518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insurance Status is an Independent Predictor of Overall Survival in Patients With Stage III Non-small-cell Lung Cancer Treated With Curative Intent.
    Rice SR; Vyfhuis MAL; Scilla KA; Burrows WM; Bhooshan N; Suntharalingam M; Edelman MJ; Feliciano J; Badiyan SN; Simone CB; Bentzen SM; Feigenberg SJ; Mohindra P
    Clin Lung Cancer; 2020 May; 21(3):e130-e141. PubMed ID: 31708388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. African-American patients are less likely to receive drug-eluting stents during percutaneous coronary intervention.
    Gaglia MA; Shavelle DM; Tun H; Bhatt J; Mehra A; Matthews RV; Clavijo L
    Cardiovasc Revasc Med; 2014 Jun; 15(4):214-8. PubMed ID: 24814420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Race, ethnicity, and socioeconomic factors in cholangiocarcinoma: What is driving disparities in receipt of treatment?
    Lee RM; Liu Y; Gamboa AC; Zaidi MY; Kooby DA; Shah MM; Cardona K; Russell MC; Maithel SK
    J Surg Oncol; 2019 Sep; 120(4):611-623. PubMed ID: 31301148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.